Member Thought Leadership
MEMBER:
Stanton Chase
In 2022, Biogen spent months searching for a new CEO. The hunt ended with the appointment of Christopher Viehbacher, but not before the company’s stock had shown notable variability and speculation had run rampant in industry circles. This high-profile search proved an inarguable fact: finding a world-class leader for a biotech firm is extraordinarily challenging.
But what exactly makes top biotech leaders so special? What elusive qualities do executive search consultants look for when they’re tasked with finding the next Henri Termeer or George Scangos?
